EP 1432418 A1 20040630 - TREATMENT OF HEPATITIS B VIRUS INFECTION WITH HUMAN MONOCLONAL ANTIBODIES
Title (en)
TREATMENT OF HEPATITIS B VIRUS INFECTION WITH HUMAN MONOCLONAL ANTIBODIES
Title (de)
BEHANDLUNG EINER HEPATITIS B INFEKTION MIT HUMANEN MONOKLONALEN ANTIKÖRPERN
Title (fr)
TRAITEMENT DES INFECTIONS PAR LE VIRUS DE L'HEPATITE B AVEC DES ANTICORPS MONOCLONAUX HUMAINS
Publication
Application
Priority
IL 0100927 W 20011004
Abstract (en)
[origin: WO03028722A1] Disclosed is a pharmaceutical composition for the treatment or prevention of hepatitis B virus infection, comprising a 1:3 mixture of two fully human anti HBsAg monoclonal antibodies 19.79 and 17.1.41. Alto disclosed are preferred modes of administration. The pharmaceutical composition can be given as a monotherapy or in combination with other anti viral agents.
IPC 1-7
IPC 8 full level
A61K 38/21 (2006.01); A61K 31/513 (2006.01); A61K 31/7088 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 39/42 (2006.01); A61P 1/16 (2006.01); A61P 31/12 (2006.01); A61P 43/00 (2006.01); C07K 16/08 (2006.01); C07K 16/18 (2006.01)
CPC (source: EP KR)
A61K 39/395 (2013.01 - KR); A61K 39/42 (2013.01 - EP); A61P 1/16 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07K 16/082 (2013.01 - EP); C07K 2317/21 (2013.01 - EP)
Citation (search report)
See references of WO 03028722A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 03028722 A1 20030410; CA 2462427 A1 20030410; CN 1558763 A 20041229; EP 1432418 A1 20040630; IL 161138 A0 20040831; JP 2005505582 A 20050224; KR 20040048935 A 20040610
DOCDB simple family (application)
IL 0100927 W 20011004; CA 2462427 A 20011004; CN 01823692 A 20011004; EP 01978778 A 20011004; IL 16113801 A 20011004; JP 2003532054 A 20011004; KR 20047004987 A 20011004